SEBI Cracks Down on Seven Entities for Social Media Stock Manipulation Freezes 20 Crore Gains
Telecom CEO Warns Europe Faces Vulnerability to US Dominance in Satellites and AI
SP 500 Edges Higher as Healthcare and Technology Lead BroadBased Gains
Vertiv Launches New Standby Power Series for North American Data Centers
National Football League Calls for Ban on Certain Prediction Market Contracts Citing Integrity Concerns
Natural Gas Futures Dip as Weather Forecasts Moderate
KLAR Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher
BNS Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Operating Performance
LASR Q1 2026 Earnings EPS Surges Past Estimates Stock Gains Amid Strategic Shifts
NEON Q1 2026 Earnings EPS Misses Estimates Amid Revenue Disclosure Gap
IRS Q1 2026 Earnings Significant Loss Reported Amidst Argentine Economic Challenges
AVIR Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment
Galapagos NV GLPG Holds Steady Near Resistance Consolidation or Catalyst Ahead
First Guaranty Bancshares Surges 7 Testing Key Resistance at 994
Intergroup Corporation INTG Edges Lower as Price Tests Key Support Near 40
Cushman Wakefield CWK Edges Higher Amid Mixed Market Sentiment
NextCure NXTC Plunges Over 22 as Selling Pressure Intensifies
Micron Technology Shares Eye Best Monthly Performance Since 1987 Analysts Flag Value Opportunity
5E Advanced Materials Inc FEAM Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Phase Continues
Karman Holdings KRMN Holds Near Support After Modest Decline
IDN Q1 2026 Earnings Strong EPS Beat Fuels Optimism Despite Lack of Revenue Detail
PNNT Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction
QNST Q1 2026 Earnings EPS Misses Estimates Stock Rises Amid Mixed Signals
DLPN Q1 2026 Earnings WiderthanExpected Loss Pressures Sentiment as Revenue Remains Undisclosed
MTX Q1 2026 Earnings EPS Surpasses Estimates by 887 Amid Solid Operational Performance
TWOD Q1 2026 Earnings Strong EPS Beat Amid Challenging Mortgage Market
AKTS Q1 2026 Earnings EPS Miss as PreRevenue Biotech Advances Pipeline